Familial Dysautonomia and Parkinson's Disease: Induced Pluripotent Stem Cell Models of Disease
Sep 17, 2015
Lorenz Studer, director at the Center for Stem Cell Biology, discusses using induced pluripotent stem cells to model human diseases and development at the 2013 Neurobiology of Disease workshop at the Society for Neuroscience’s annual meeting.
Access to the full article is available to SfN members.
Neuronline is a benefit of SfN membership. Renew your membership now to make sure you don’t lose access.
Speaker
Lorenz P. Studer, MD
Lorenz Studer is the director of the Center for Stem Cell Biology and a member of the developmental biology program at the Memorial Sloan Kettering Cancer Center. His lab has established many of the currently available techniques for turning pluripotent stem cells into the diverse cell types of the nervous system. His primary research interest is in regenerative medicine, and he leads a multidisciplinary consortium to pursue the clinical application of human stem cell-derived dopamine neurons for the treatment of Parkinson's disease.
0 of 5 articles left
Login
or
Become a Member
to unlock content
